Sample 1
Sample 1
For questions 1-30, please refer to the Poisons Act 1952 and its Regulations
-
A. Group A Poisons (by wholesale)
B. Group B Poisons
C. Group C Poisons
D. Group D Poisons
2. Mr. AB, a registered pharmacist, owns a retail pharmacy in Kuala Krai. He is licensed under the
Act to do retail at his business premises. Under the Act Mr. AB may
group [
2
I. Import mefenamic acid BP powder. -> page
* all Poison
group C
O
A. I and II only ↳ steroid private -
license type A
A. I and II only
O
C. III and IV only
4. Type A licensed holder shall make an entry into the Poisons Wholesale Sales Book for the sale to
a government hospital of the following items:
Group
C
I. Salbutamol inhaler - Ru book
1
II. Tetracycline capsules
A. I only
IV. Cloxacillin 250 mg capsule for the purpose of animal treatment with prescription.
B. I and IV only
6. A strip of bisacodyl 5 mg tablet was dispensed by a pharmacy assistant without a prescription while
the licensed pharmacist was in the same room within the premises. The sale was not recorded in
a Prescription Book. The following is TRUE regarding the sale:
A. I only
B. II only
C. II and IV only
7. Licensed pharmacist selling atenolol 100 mg on a prescription shall, at the time of selling, endorse
upon the face of the prescription, above the signature of the prescriber, with the following
particulars:
2
A. I, II, and III only
C. II and IV only
8. The following articles and preparations are exempted under the Act:
A. I and II only
9. A traditional healer center was suspected of dispensing antibiotic capsules to their customers. The
state drug enforcement officers were tasked to conduct a raid on the premise. The following
statements are TRUE regarding the power of an authorized officer:
II. He can search and remove the documents from the premise
III. He can enter the premise by breaking open the door of the premise
IV. He can destroy the antibiotics in the presence of the owner of the premise
A. I and II only
III. Shall publish the name of the licence holders in the gazette annually
IV. May authorize in writing any registered pharmacist to exercise the powers of a Drug
Enforcement Officer
A. I and II only
B. I and IV only
3
D. All of the above
B. I and IV only
12. The following statements are TRUE regarding registered diltiazem 30 mg tablet:
IV. A permit to purchase and use is required by a tradesman for the purpose of such person’s
trade only
A. I and II only
II. “Medical treatment” means the treatment of human and animal diseases
III. “Licensed wholesale” means a person holding a licence issued to him to sell poisons by
wholesale and retail
IV. “Conveyance” includes ship, train, vehicle, aircraft or any other means of transport by which
persons or goods can be carried
A. I and II only
C. I and IV only
D. IV only
I. A seller sold Sodium Hydroxide 15% to Tung Shin Hospital shall record the sale in the Poisons
Book
4
II. A retailer sold Group D Poisons other than as dispensed medicine, shall record the sale in the
Poisons Book
III. A licensed pharmacist sold atenolol 100 mg tablet as dispensed medicine, shall enter the
sales into the Prescription Book
IV. A licenced chemical company sold 20 drums hydrochloric acid 20% to Shell Malaysia shall
make an entry into the Poisons Wholesale Sales Book
A. I and II only
15. The following statements are TRUE of the Act and its Regulations:
I. Type A licence holder may import any poison in the Poisons List
II. Any amendment to the Poisons List shall be made by the Poison Board
III. Dispensed medicine involves the supply of Group A, Group B and Group C poisons on a
prescription only
IV. Supply of metformin tablet by a licensed pharmacist without a prescription does not
contravene any provision under the Act.
A. I and II only
B. I and IV only
D. II and IV only
16. The following are the labelling requirements of cortisone cream as a dispensed medicine:
I. Name of Medicine
IV. The words “Not the be Taken” in English, Malay, Chinese, and Tamil in red or in a red
background
B. I, II and IV only
C. II and IV only
5
III. All miconazole preparations are in Group B, unless it is in Group C.
IV. All preparations of chloramphenicol in pharmaceutical dosage form are in Group B unless in
Group C and Group D.
B. I, II and IV only
18. The following combinations are TRUE regarding offences and penalties under the Act and its
regulations:
Offence Penalty
II Failed to record the sale of paracetamol 500 Fine not exceeding RM5000.00 or by
mg tablet in the Prescription Book by licensed imprisonment for a term not exceeding two
pharmacist years or both
III Making false records of poison sale in the Fine not exceeding RM5000.00 or by
Poison Wholesale Sales Book imprisonment for a term not exceeding two
years or both
A. I and II only
I. The Act regulates the importation, possession, manufacture, compounding, storage, transport,
sale and use of poisons.
II. Importation of concentrated ethyl fluid is subjected to the licence issued by the licensing officer
and the fee of the licence is RM100.00.
III. Any poisons in respect of which an offence against the Act has been committed shall be
forfeited and delivered to the General Director of Health for disposal.
IV. A person may import into Malaysia a prepared medicine containing poison by parcel post for
his own personal use for a quantity reasonably required for one month’s usage.
A. I and II only
C. II and IV only
6
D. All of the above
I. Estate workers
A. I and II only
21. The following particulars must be recorded in the Poisons Wholesale Sales Book EXCEPT:
IV. Seller’s name, identity card number, signature and telephone number
A. I and II only
D. IV only
I. The Director of Pharmaceutical Services is the Licensing Officer for issuing licences for the
purpose of this Act.
III. Tadalafil 2.5 mg tablet can be supplied by wholesale by registered medical practitioner to a
registered medical practitioner.
IV. Type A licence issued to any person whom the Licensing Officer may consider to be a fit and
proper person to hold such as licence.
A. I and II only
23. The following combinations are TRUE regarding recording of the sale or supply of poisons under
the Act:
7
Poisons Name of Records
A. I and II only
B. I, II and IV only
24. The following statements are FALSE regarding supply of poison for the purpose of treatment by
professional men:
I. Diclofenac 50 mg tablet can be supplied by a veterinary officer to his client for the purpose of
animal treatment only.
II. Group A Poison can be supplied by a registered medical practitioner for the purpose of the
medical treatment of such patient only.
III. Amoxycillin 250 mg capsule can be supplied by a registered dentist Division II for the purpose
of the dental treatment of such patient only.
IV. Mefenamic acid 500 mg capsule can be supplied by a registered dentist Division I for the
purpose of the dental treatment of such patient only.
A. I and II only
25. A registered medical practitioner may administer to his patient for medical treatment of such patient
following poisons EXCEPT :
II. Ipronidazole
III. Amidopyrine
IV. Ketoconazole
A. I and II only
8
D. All of above
26. She shall enter in a record kept for such supply the following particulars:
IV. The name and address of the person to whom the poison was supplied.
C. II and IV only
27. She shall label the container of the poison with the following particulars:
C. II and IV only
28. The following statements are TRUE regarding "immediate personal supervision relating to Part I
Poisons:
I. Group A poisons may be sold under the immediate personal supervision of the
II. Every medicine containing any poison shall be prepared by or under the immediate personal
supervision of a registered medical practitioner.
III. A person working under the immediate personal supervision of a registered pharmacist may
dispense, compound or mix any poison with any other substance.
IV. Any compounding of any poisons with any other substance is required to be do under the
immediate personal supervision of any person, it shall not be deemed have been so done unless
such person has himself checked such compounding.
A. I only
B. II and IV only
9
C. II, III and IV only
29. The following statements are TRUE regarding establishment and proceeding Poisons Board:
II. The Minister may appoint a Secretary to the Board who shall be a member of the Board and
have the right to vote.
III. No action or proceeding of the Board shall be questioned on the ground of any omission, defect
or irregularity in procedure not affecting the merits of the case
IV. The Board shall meet at such places and times as the Chairman may appoint and at any
meeting four members including the Chairman or member presiding shal form a quorum.
A. I and II only
30. Mr. A compounds and mix poison with other substance. The activities DO NOT contravene the Act
if:
III. Mr. A is a pharmacy assistant working in the private hospital in absence of a registered
pharmacist.
IV. Mr. A is a person working under immediate personal supervision of a registered medical
practitioner for the use of such patient.
A. I and II only
B. II and IV only
For questions 31 - 40, please refer to the Poisons (Psychotropic Substances) Regulations 1989.
31. The following persons authorized to be in possession of psychotropic substance shall keep and
maintain a register to be called the 'Register of Psychotropic Substance Received, Delivered or
Administered":
I. A veterinary surgeon
A. I and II only
10
B. I, II and III only
A. Custom Officer is empowered to issue certificates and authorisations for and export of
psychotropic substances.
B. An officer of the Postal Department, acting in the course of his duty shall not be authorised to
be in possession of psychotropic substances.
C. At the time of importation, the importer shall produce to the competent authority the import
authorisation relating to the psychotropic substances.
D. International carriage by ships may leave Malaysia with limited quantities of psychotropic
substances required during their journey for emergency cases.
33. Tablets of zopiclone which are delivered by an authorized person shall be recorded in the
III. is valid for 120 days after the date of the prescription.
B. I and II only
35. In carrying out his duty the following person may possess registered oxycodone syrup for the
purpose of medical treatment:
I. A biochemist
A. I and II only
11
C. II and IV only
36. A pharmacist wrongly entered the date, name and the quantity of the psychotropic substance
received and delivered in the registerWhat action should he take according to the Regulations?
D. Make a footnote, specify the date on which the correction was made
II. Mesocarb -
Ill. Lisdexamphetamine -
A. I and IV only
38. Choose the correct combinations for X, Y, and Z regarding the import of psychotropic substances.
Every psychotropic substance specified in the ___X___ which is imported into Malaysia, or brought to
Malaysia in transit, from a country which is a party to the Convention shall be accompanied by a valid
and subsisting ___Y___ duly issued by the competent authority of the country from which it is exported;
and the person having the possession or control of such psychotropic substance shall, on demand by
any Drug Enforcement Officer, any police officer not below the rank of inspector or any senior officer of
Customs, produce such export authorization for his ___Z___.
X Y Z
39. The following persons shall dispose psychotropic substance in their possession the presence of a
Drug Enforcement Officer:
I. A registered dentist Division who is required to keep and maintain "Prescription Register for
Psychotropic Substance". I
II. A pharmacist in the public service who is required to keep and maintain Supply Register for
Psychotropic Substance". -
12
III. A licensed pharmacist who is required to keep and maintain Production Register for
Psychotropic Substance".
IV. The holder of a permit issued under Regulation 15 who is required to keep and maintain
"Register of Psychotropic Substance Received, Delivered or Administered
C. II and IV only
Sale or supply for other than medical, Supply Register for Psychotropic Substances
II dental or animal treatment
Supply for medical, dental and animal Prescription Register for Psychotropic
III treatment Substances
B. I, II and IV only
For questions 41 - 60, please refer to the Sale of Drugs Act 1952 and Control of Drugs and
Cosmetics Regulations 1984.
41. The Director of Pharmaceutical Services shall have the powers to issue:
IV. certification on any matter relating to any cosmetic as may be required by the importing country
of such cosmetic.
A. I and II only
13
B. I, Ill and IV only
The officers inspected a traditional medicine manufacturing plant which was producing suspected
unregistered product. The product was seized for further investigation. The Secretary to the Drug
Control Authority later confirmed that the product was not a registered product.
I. Regulation 7(1)(a)
IV. Regulation 7A
A. I only
B. I and II only
III. Make regulations to improve the carrying out of the provisions of the Act.
IV. Appoint such number of officers within a State as may be necessary for the purposes of the Act. Y
A. I and II only
B. I and IV only d
C. Il and III only
45. The notification notes issued by the Director of Pharmaceutical Services allows any cosmetic to be:
I. possessed.
14
II. manufactured.
A. I and II only
A. officers.
B. analysts.
C. inspectors.
I. manufacturer's licence
A. I and II only
48. The Director of Pharmaceutical Services may issue such written directives or guidelines to any
person or a group of persons which in particular relate to:
IV. records and statistics pertaining to manufacture, sale, supply, import or export of any products.
B. I, Il and IV only
C. Il and IV only
15
49. In the case of any conviction under the Act:
I. The name and occupation of the person who commits the offence may be published
in any newspaper. -
II. The person who without authority removes any seal placed by any officer shall be liable to a
fine of RM5000.00. RIl RM500 X
-
III. Any drug to which the conviction relates shall be forfeited and shall be disposed as directed by
the Chief Minister.
IV. The body corporate that commits an offence of manufacturing any product without any licence
shall be liable to a fine not exceeding RM25,000.00 or to imprisonment for a term not exceeding
three years or to both.
B. II and IV only X
C. III only X
50. The register of the products registered under the Regulations shall:
III. Contain the name and address of the product registration holder. -
IV. Be preserved for a period of two years from the date of last entry in such register.
A. I and II only X
51. The following statements are TRUE regarding clinical trial import licence under the Regulations:
exceeding 3 year s
not
I. A clinical trial import licence shall be valid for five years.
~
X
R12(2)
II. Any number of registered products may be included in a clinical trial import licence. X (not applicable (
III. A clinical trial import licence authorises the licensee to import any product for purposes of
clinical trial.
IV. An application for a clinical trial import licence shall be made in Form 4 and accompanied with
a processing fee of RM 500.00.
B. I and IV only X
16
II. Selling an unregistered ketum capsule to a friend.
A. I and II only
B. I, II and IV only
I. Caffeine -
II. Charcoal
A. I and II only
D. IV only X
54. Madam FAA arrives in Malaysia after spending two weeks in Seoul shopping for cosmetics and
beauty products. She carried with her as part of her personal luggage, 72 pieces snail serum facial
masks made in Korea. The facial masks are not notified cosmetics. The instruction of use is one mask
daily. The following statements are TRUE regarding the case above:
A. I and II only X
55. An article intended to be used on humans or any animal for medicinal purposes is a "drug” under
the Act if it is for the following purposes:
I. Including anaesthesia. -
17
A. I and II only
56. The manufacturing of a product for teaching or research purposes may be exempted from the
requirement of registration in relation to the manufacturing, sale, supply, possession, and administration
of such product if the application for the exemption is made by the following persons:
A. I and II only
B. I, II and IV only
57. The following statements are FALSE regarding the person responsible for placing the notified
cosmetic in the market:
I. Report to the Director of Pharmaceutical Services for any serious adverse events.
II. Maintain proper records in the manner determined by the Director of Pharmaceutical Services.
III. Comply to the directives issued by the Minister of Health and conditions imposed by the Director
of Pharmaceutical Services.
IV. May apply for the issuance of the notification note to the Director of Pharmaceutical Services
and the processing fee is refundable.
A. I and II only
A. Written application may be made to the Secretary and payment of RM5.00 to inspect the
register.
B. The Authority may at any time and without assigning any reason, reject the registration of any
product.
C. Cancellation of registration of any product in the licence will affect the position of other products
listed in the licence.
18
D. Product registration holders shall immediately inform the Director of Pharmaceutical Services
of any adverse reactions from the use of the registered product.
60. The following statements are TRUE regarding legal proceeding and evidence under the Act:
I. All proceedings of an offence against this Act shall be taken before a High Court.
II. There shall be served with the summons a copy of the analyst's certificate, if any, on which the
prosecution is based.
III. The summons in any such proceedings shall not be made returnable in less than fourteen days
from the day on which it is served.
IV. The certificate of analysis issued by the analyst is sufficient as evidence unless the defendant
requires that the analyst is called as a witness.
A. I and IV only
For questions 61 - 75, please refer to the Registration of Pharmacists Act 1951 and its
Regulations.
61. A registered pharmacist in Malaysia has been sentenced to two months imprisonment in a
neighbouring country due to drug related offences. If it comes to the knowledge of the Pharmacy
Board, it may inquire into the case under the following provision(s) of the Act:
I. Section 17(1)(a)
A. I only
B. I and II only
D. IV only
62. The Minister need not consult the Pharmacy Board regarding the:
II. Decision for the appeal against the removal of registered pharmacists name from the register.
19
III. Imposition of restrictions and conditions on any person provisionally registered under paragraph
6(1)(b).
A. I and lI only
B. Il only
A. Minister.
64. A provisionally registered pharmacist who has satisfactory experience wishes to apply for full
registration shall be in
A. Form 2.
B. Form 3.
C. Form 5.
D. Form 6.
C. II and IV only
66. The following statements are TRUE regarding provisional registration for pharmacists:
III. Limited to persons who hold any qualification specified in the First Schedule.
20
IV. The Minister after consulting the Board may amend the First Schedule by order published in
the Gazette.
A. I and II only
B. I, II and IV only
67. A provisionally registered pharmacist shall engage in employment as a pharmacist in the following
approved premises which fulfil the criteria for the purpose of training:
I. Private hospitals
A. I, II and IV only
B. Ill only
II. The title of pharmacist can only be used by person registered under the Act.
III. If a person not registered under the Act uses the title pharmacist, he shall be guilty of an offence.
IV. Conviction of a person guilty of an offence under Section 7 of the Act has to be of an offence.
made in a high court.
A. I and II only
D. I, II and IV only
69. The following interpretations are TRUE under the Act or its Regulations:
I. "therapeutic substance" means drug as defined in the Sale of Drugs Act 1952.
II. "psychotropic substance" means any of the substances specified in the Third Schedule to the
Poisons Act 1952.
III. "poison" means any article deemed to be a poison within the meaning of the Poisons Act 1952
or of any other written law relating to poisons in force in Malaysia.
IV. "Dangerous drug" means any drug or substance which is for the time being comprise in the First
Schedule to the Dangerous Drugs Act 1952 or any corresponding schedule to any other written law
relating to dangerous drugs in force in Malaysia.
A. I and II only
21
B. I, III and IV only
70. The following statements are TRUE regarding the registration of pharmacists:
I. A person shall be entitled to be a fully registered pharmacist under this Act after gaining
experience as required under Section 6A.
II. The Pharmacy Board may, upon application in writing, temporarily register a person who is
registered as a pharmacist outside Malaysia.
III. The name of a registered pharmacist may be removed from the register by the Pharmacy Board
if such person has permanently left Malaysia.
IV. The Board may extend for not more than one year from the period of employment if the Board
is not satisfied with the performance of the provisionally registered pharmacist.
A. I and II only
II. A registered pharmacist shall be the superintendent of a body corporate at any time.
III. It may appeal to the Minister if it is aggrieved by any of the punishments imposed by the Board.
IV. If it fails to obtain an annual certificate for the coming year, its name will be removed
A. I and II only
72. The following is the duty of the Secretary of the Pharmacy Board:
III. Publish in the Gazette a list of all registered pharmacists and bodies corporate.
IV. Remove the name of a registered pharmacist from the register if such person is decreased.
B. II and IV only
22
D. None of the above
73. Every application for full registration shall be accompanied by such documents and fee as
prescribed under the Regulations:
I. A fee of RM100.00
III. A certified true copy of the appointment letter as provisionally registered pharmacist
IV. A certificate of satisfactory experience issued under subsection 6A(2) of the Act or a certificate
of exemption issued under section 6A(7) of the Act or a certificate issued by the Minister under
subsection 6B(3) of the Act
B. I, II and IV only
C. II and IV only
74. The following is the correct order regarding any person who seeks to make a complaint against a
registered pharmacist:
IV. The Committee of Inquiry makes an investigation and reports to the Board
A. I, II, III, IV
B. I, III, II, IV
C. II, I, III, IV
D. III, II, I, IV
75. Under the Act, the Board may make regulations for and in respect of all or any of the following
matters:
II. The establishment of a Committee of Inquiry to inquire into complaints or information regarding
any misconduct by any registered pharmacist.
III. The examination prescribed or set by the Board to be passed by any person before he is eligible
to apply to be admitted to the register under this Act.
IV. The pupillage, the conditions under which the practical training of apprentices or students shall
be conducted and any other matter relating to the training and qualification of pharmacists.
A. I and II only
23
D. All of the above
For questions 76 - 85, please refer to the Medicines (Advertisement and Sale) Act 1956.
76. An advertisement relating to the following may be approved by Medicine Advertisements Board for
the public.
A. I only
I. by the Board.
A. I only
B. III only
D. II and IV only
78. In the context of advertisement, substance recommended as a medicine in relation to the sale of
an article consisting or comprising a substance, among others could refers to:
IV. placard or document exhibited at the place where the article is sold.
B. I and IV only
C. II and IV only
79. The Minister may approve the publication of an advertisement which refers to any skill or service
relating to medical matters by:
I. a private clinic.
24
II. a private hospital. -
A. I and II only
A. Section 3
B. Section 4 Cabortion )
C. Section 4A (service(
D. Section 4B (meds)
I. In the context of the Act, “word” includes letter and numeral. - S(2)
II. A written sanction is needed to prosecute offences under the Act. ~ S6F
III. The Board may invite any one or more persons to attend the Board meeting and the person
shall have no right to vote. R3
IV. Any person contravene Section 6 shall be subjected to a fine not exceeding RM3000.00 or
imprisonment not exceeding one year. or both SGE
A. I and II only
C. I and IV only
25
D. All of the above
82. The following online advertisement was found circulating the Facebook messenger chat group.
Are you experiencing hands and feet numbness? Try our innovative ABC capsules now!
ABC capsules are also effective for the treatment of diabetes. Safe and endorsed by health care
professionals. Please enquire by texting 017-245365 (Dr GHT)
A. Section 3
B. Section 4A
C. Section 4B
83. Mr.S, a traditional practitioner advertises his special concoction of medicine in the form of a
leaflet. The capsules were produced in his clinic and they were indicated to treat joint pain. With
regards to the Act, the advertisement
A. contravenes section 3.
I. The Board may add to, delete from or amend the Schedule from time to time by order.
II. advertisements relating to abortion medicines can be advertise by private clinic after getting
approval from the Board.
III. “public hospital” includes public clinic, public dispensary or other public institution for the
reception of the sick patient.
IV. prohibition advertisements relating to certain diseases under Schedule shall not apply to any
advertisement published by the Federal Government
A. I and II only
C. IV only
85. The powers vested upon the Minister under the Act or its Regulation include to:
26
III. exempt any person from the payment of fee for the application for approval of advertisement.
IV. authorize in writing any pharmacist in the public service to exercise the powers of an
authorized officer under the Act.
A. I and II only
C. IV only
For questions 86 - 90, please refer to the Dangerous Drugs Act 1952 and its Regulation.
87. A registered pharmacist shall not supply any dangerous drug to any person authorized under
Regulation 8 unless the following conditions are fulfilled:
I. He has entered in the Register the amount and form of drug supplied.
II. The drug sold, if sent by post to the purchaser, must be sent by registered or insured post.
III. He is reasonably satisfied that the signature affixed to the order is in fact the signature of the
authorized person purporting to sign it
IV. He has received an order in writing signed by the purchaser stating his name and address
and the name and quantity of the drug to be purchased.
C. II and IV only
I. It is a dangerous drug which is for the time being comprised in the Part III of the First Schedule
to the Act.
II. It can be imported into Malaysia under and in accordance with the authorization in the Form B
set out in the Second Schedule to the Act.
III. The Minister of Health may authorize any public officer to cultivate cannabis for research,
educational, experimental, or medical purposes.
IV. The Minister may make regulations for prohibiting the cultivation, production, possession, sale
and distribution of cannabis.
A. I and II only
27
B. I and IV only
89. Every prescription issued by a registered medical practitioner for the supply of a dangerous drug
for the medical treatment of a patient must:
III. specify the name and address of the person for whose treatment it is given.
IV. be in writing and signed by the person giving it with his usual signature and dated by him.
B. I and II only
90. The Minister have a power under the Act and its regulations EXCEPT:
I. may appoint such persons as he may think fit to be Drug Enforcement Officers for the purposes
of this Act.
II. may make regulations for the further, better and more convenient carrying out of the provisions
or purposes of this Act.
III. to delegate to any fit and proper officer authority to exercise any of the powers and functions
vested in the Minister by this Act.
IV. exempt from any of the provisions of this Act or the regulations any hospital, infirmary,
dispensary maintained by a public authority.
A. I only
B. I and II only
For questions 91-94, please refer to the Code of Ethics for Pharmacists 2018.
91. The pharmacist has been convicted of selling unregistered product that are unsafe, ineffective and
of poor quality. He has breached:
A. Principle 7
B. Principle 5
C. Principle 3
D. Principle 4
28
92. "Explain the options available to patients and the public, including risks and benefits, to help them
make informed decisions, make sure the information given is impartial, relevant, accurate and up
to date".
D. Encourage Patients and the Public to Participate in Decisions About Their Care
93. "A pharmacist possessed and sold medicines labelled with "Kementerian Kesihatan Malaysia"
without a valid document or authorization for his personal financial gain".
I. Principle 1
II. Principle 2
III. Principle 6
IV. Principle 7
A. I and II only
D. IV only
94. Pharmacist Q has sold expired medications to a patient. The following statements are TRUE related
to the above situation:
II. The pharmacist failed to protect patient privacy as in Principle 3 of the Code.
III. The pharmacist failed to practice safe procedure as suggested in Principle 1 of the Code.
IV. The pharmacist failed to take the responsibility to provide a service as in Principle 7 of the Code.
A. I and II only
C. II and IV only
For questions 95 - 97, please refer to the Framework for Good Governance in Medicine.
95. The selection of medicines into the formulary which forms the basis for the procurement by
specialists is vulnerable to corrupt practice when
29
20920
III. samples are given freely to the specialists resulting in indiscriminate use. pg
A. I and II only X
96. According to Good Governance for Medicines (GGM) regarding the inspection of manufacturers
and issuing of manufacturer's license
97. A pharmacist in a public hospital took 10 tablets of diazepam from the outpatient dispensary and
sold them to a patient for RM20.00. He then pocketed the money. The pharmacist has committed
A. theft
B. bribery
C. cheating
D. disgraceful conduct
For questions 98 - 100, please refer to the Malaysian National Medicines Policy (Dasar Ubat
Nasional, DUNas) 3rd Edition 2017-2021.
98. The following statements are TRUE regarding strategies to ensure provision of Safe and Quality
Use of Medicines:
IV. Enhanced community engagement to encourage safe and effective use of medicines by
consumers. -
B. II and IV only X
99. The following statements are TRUE regarding strategies to ensure adequate and equitable access
to quality medicines. page 14
30
II. Continuous exemption of tariff and duties on all medicines.
IV. Rationalisation of medicines pricing system in the public and private sector.
A. I and II only
B. I, II and IV only
100. The following statements are TRUE about Malaysian National Medicines Policy:
II. It is an official document that defines and prioritize goals of the country's pharmaceutical
sector.
III. It establishes framework and strategy plans for the implementation of pharmaceutical
initiatives in public and private sectors.
IV. The principal objective is to improve health outcomes of Malaysians by promoting equitable
access to essential medicines, promoting rational use of medicines and ensuring quality,
safety, effectiveness and affordability of medicines.
A. I and IV only
31